Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives
Five families of investigational products are in clinical investigation to slow or reverse normal aging processes [longevity candidates, mesenchymal stem cells, senolytics drugs, sirtuin activators, and nicotinamide adenine dinucleotide (NAD)+ precursors]. The longevity candidates, vitamin D and met...
Saved in:
Main Author: | Ricardo P. Garay |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-04-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100840/100840.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Intersection of Epigenetics and Senolytics in Mechanisms of Aging and Therapeutic Approaches
by: Daiana Burdusel, et al.
Published: (2024-12-01) -
Bioactive Anti-Aging Substances: Geroprotectors
by: Anna D. Fokina, et al.
Published: (2024-05-01) -
Split-face intradermal botulinum toxin versus saline injection for facial aging: a single-center study
by: Hala M. Elbasiony, et al.
Published: (2024-01-01) -
Genetics of aging and longevity
by: A. A. Moskalev, et al.
Published: (2016-09-01) -
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
by: Nathalia Silva Dutra Alves, et al.
Published: (2025-02-01)